Invest in Israel – Two Digital Health Companies

Israel Today is dedicated to connecting our readers to the Israeli startup scene, and giving you a chance to invest in the future of the Jewish state

By Israel Today Staff | | Topics: Invest in Israel

Israel Today is passionate about building connections between our readers and Israeli startups. Because whoever blesses Israel will in turn be blessed, and this can also mean material blessings.

We have already successfully completed two rounds of financing for local startups. For the third, we have carefully selected two very special Israeli companies that you can invest in as a shareholder with a minimum investment of 15,000 euros ($16,000 USD).

 

BioXtreme and NanoVation

BioXtreme’s breakthrough motor learning technology significantly shortens limb rehabilitation after a stroke and improves outcomes by 100 percent, reducing rehabilitation time by 50 percent. The effectiveness of this unique patented device has been proven in clinical studies and is now ready for the global market.

Having completed clinical studies and received FDA, CE and AMR approvals, BioXtreme is now ready for commercialization. The company is working on strategic investments and has already signed contracts for international distribution and cooperation. BioXtreme offers attractive intellectual property and unique patents registered in Israel, the US and Europe. This is an exciting opportunity in a fast-growing market with great potential for expansion into other sectors.

NanoVation has developed innovative technology to monitor respiration in patients with chronic lung disease. The monitor detects early symptoms of the disease, shortening the length of hospital stays and significantly reducing the need for repeat hospitalizations. The system is based on advanced nanosensor technology that acts as a kind of ECG monitor for the lungs during and after the hospital stay. The system is unique, easy to use at home or in a clinic, and non-invasive.

The groundbreaking technology was developed and patented at the Technion in Haifa. The company is the sole owner of the first patent, two further patents are currently pending. The company has received both a grant and an investment from the European Innovation Council (EIC). It boasts significant results from eight successful clinical trials conducted in leading medical institutes in Israel and around the world. CE approval and certification according to international ISO standards available. Over 700 million patients worldwide can benefit from the technology. Other benefits include huge financial savings for hospitals, healthcare providers and insurance companies.

 

If you are interested in investing in either of these companies, write to us at [email protected] and we will get back to you.

 

Israel Today Newsletter

Daily news

FREE to your inbox

Israel Heute Newsletter

Tägliche Nachrichten

KOSTENLOS in Ihrer Inbox